BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35061117)

  • 21. Next-Generation HIV Pre-Exposure Prophylaxis Preferences Among Men Who Have Sex with Men Taking Daily Oral Pre-Exposure Prophylaxis.
    Ellison J; van den Berg JJ; Montgomery MC; Tao J; Pashankar R; Mimiaga MJ; Chan PA
    AIDS Patient Care STDS; 2019 Nov; 33(11):482-491. PubMed ID: 31603712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is high.
    Hatch MA; Laschober TC; Paschen-Wolff M; Ertl MM; Nelson CM; Wright L; Lancaster C; Feaster DJ; Forrest D; Hankey C; Monger M; Fegley JP; Irving R; Young C; Rose J; Spector A; Dresser L; Moran L; Jelstrom E; Tross S
    Drug Alcohol Depend; 2024 Apr; 257():111133. PubMed ID: 38447393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of Preexposure Prophylaxis Cascade Among Sexual and Gender Minorities in Nigeria.
    Ramadhani HO; Crowell TA; Nowak RG; Adebajo S; Kayode BO; Ononaku U; Baral SD; Ndembi N; Charurat ME;
    Sex Transm Dis; 2023 Sep; 50(9):559-566. PubMed ID: 37277897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferences for Long-Acting and Alternative Modalities for PrEP among Military Men Who Have Sex with Men: Segmentation Results of an Adaptive Choice-Based Conjoint Analysis Study.
    Gutierrez JI; Vlahov D; Dubov A; Altice FL
    J Urban Health; 2022 Apr; 99(2):277-292. PubMed ID: 35318573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferences for long-acting pre-exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey.
    Hsu JH; Ku SW; Chen TW; Li CW; Huang P; Wu HJ; Bourne A; Strong C
    J Int AIDS Soc; 2023 Sep; 26(9):e26163. PubMed ID: 37675767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical Mistrust and the PrEP Cascade Among Latino Sexual Minority Men.
    Kimball D; Rivera D; Gonzales M; Blashill AJ
    AIDS Behav; 2020 Dec; 24(12):3456-3461. PubMed ID: 32405726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rates of Pre-exposure Prophylaxis Use and Discontinuation Among a Large U.S. National Sample of Sexual Minority Men and Adolescents.
    Whitfield THF; Parsons JT; Rendina HJ
    Arch Sex Behav; 2020 Jan; 49(1):103-112. PubMed ID: 31845148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examining the Awareness, Acceptability, and Adoption of Conventional and non-conventional Forms of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among jail-involved Black Sexual Minority men (BSMM) and Black Transgender Women (BTW) in Two Diverse US Cities.
    Jones MD; Jones K; Almirol E; Payne G; Graves B; Schneider JA; Rijos D; Zawitz C; Zimmerman R; Seal DW; Brewer R; DrPH RB
    AIDS Behav; 2023 Apr; 27(4):1304-1313. PubMed ID: 36264406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. To switch or not to switch: Intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experience.
    Meyers K; Wu Y; Brill A; Sandfort T; Golub SA
    PLoS One; 2018; 13(7):e0200296. PubMed ID: 30024903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferences Across Pre-Exposure Prophylaxis Modalities Among Young Men Who Have Sex with Men in the United States: A Latent Class Analysis Study.
    Valente PK; Bauermeister JA; Lin WY; Silva DTD; Hightow-Weidman L; Drab R; Mayer KH; Operario D; Rusley J; Biello KB
    AIDS Patient Care STDS; 2022 Nov; 36(11):431-442. PubMed ID: 36367995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China.
    Meyers K; Wu Y; Qian H; Sandfort T; Huang X; Xu J; Zhang J; Xia W; Glidden D; Wu H; Shang H
    AIDS Behav; 2018 Apr; 22(4):1217-1227. PubMed ID: 28707025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Need for informed providers: exploring LA-PrEP access in focus groups with PrEP-indicated communities in Baltimore, Maryland.
    Kaptchuk RP; Thomas AM; Dhir AM; Solomon SS; Clipman SJ
    BMC Public Health; 2024 May; 24(1):1258. PubMed ID: 38720248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Running with Scissors: a Systematic Review of Substance Use and the Pre-exposure Prophylaxis Care Continuum Among Sexual Minority Men.
    Viamonte M; Ghanooni D; Reynolds JM; Grov C; Carrico AW
    Curr HIV/AIDS Rep; 2022 Aug; 19(4):235-250. PubMed ID: 35701713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?
    John SA; Whitfield THF; Rendina HJ; Parsons JT; Grov C
    AIDS Behav; 2018 Apr; 22(4):1184-1189. PubMed ID: 28913659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts.
    Shamu S; Shamu P; Khupakonke S; Farirai T; Chidarikire T; Guloba G; Nkhwashu N
    Glob Health Action; 2021 Jan; 14(1):1886455. PubMed ID: 33606603
    [No Abstract]   [Full Text] [Related]  

  • 36. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.
    Shorrock F; Alvarenga A; Hailey-Fair K; Vickroy W; Cos T; Kwait J; Trexler C; Wirtz AL; Galai N; Beyrer C; Celentano D; Arrington-Sanders R
    AIDS Patient Care STDS; 2022 May; 36(5):194-203. PubMed ID: 35507322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among Young Adult Sexual Minority Men and Transgender Women.
    Weeden T; Garofalo R; Johnson AK; Schnall R; Cervantes M; Scherr T; Kuhns LM
    Acad Pediatr; 2024 Apr; ():. PubMed ID: 38631476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
    Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model.
    Maloney KM; Le Guillou A; Driggers RA; Sarkar S; Anderson EJ; Malik AA; Jenness SM
    J Infect Dis; 2021 Jan; 223(1):72-82. PubMed ID: 32882043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Willingness to Use and Adhere to HIV Pre-Exposure Prophylaxis (PrEP) among Men Who Have Sex with Men (MSM) in China.
    Peng L; Cao W; Gu J; Hao C; Li J; Wei D; Li J
    Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31340482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.